Chapter 1. EYE HEALTH SUPPLEMENTS MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. EYE HEALTH SUPPLEMENTS MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-110 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. EYE HEALTH SUPPLEMENTS MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. EYE HEALTH SUPPLEMENTS MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. EYE HEALTH SUPPLEMENTS MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. EYE HEALTH SUPPLEMENTS MARKET– By Form
6.1. Tablets
6.2. Capsules
6.3. Powder
6.4. Others
Chapter 7. EYE HEALTH SUPPLEMENTS MARKET– By Indication
7.1. Age-related Macular Degeneration (AMD)
7.2. Cataract
7.3. Dry Eye Syndrome
7.4. Inflammation
7.5. Others
Chapter 8. EYE HEALTH SUPPLEMENTS MARKET– By Ingredient Type
8.1. Lutein and Zeaxanthin
8.2. Antioxidants
8.3. Omega-3 Fatty Acids
8.4. Coenzyme Q10
8.5. Flavonoids
8.6. Alpha-Lipoic Acid
8.7. Others
Chapter 9. EYE HEALTH SUPPLEMENTS MARKET– By Region
9.1. North America
9.2. Europe
9.3. The Asia Pacific
9.4. Latin America
9.5. Middle-East and Africa
Chapter 10. EYE HEALTH SUPPLEMENTS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. Company 1
10.2. Company 2
10.3. Company 3
10.4. Company 4
10.5. Company 5
10.6. Company 6
10.7. Company 7
10.8. Company 8
10.9. Company 9
10.10. Company 10
2850
5250
4500
1800